ENGN enGene Holdings Inc.

Nasdaq


$ 8.79 $ -0.01 (-0.11 %)    

Wednesday, 15-Oct-2025 15:59:53 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 8.8
$ 8.90
$ 8.24 x 20
$ 10.00 x 200
$ 8.36 - $ 9.01
$ 2.65 - $ 11.00
309,838
na
449.73M
$ 0.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-11-2025 07-31-2025 10-Q
2 06-12-2025 04-30-2025 10-Q
3 03-10-2025 01-31-2025 10-Q
4 12-19-2024 10-31-2024 10-K
5 09-10-2024 07-31-2024 10-Q
6 06-14-2024 04-30-2024 10-Q
7 03-11-2024 01-31-2024 10-Q
8 01-29-2024 10-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Morgan Stanley analyst Jeffrey Hung maintains enGene Holdings (NASDAQ:ENGN) with a Overweight and lowers the price target fr...

Core News & Articles

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates enGene Holdings (NASDAQ:ENGN) with a Buy and maintains $25 pr...

Core News & Articles

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates enGene Holdings (NASDAQ:ENGN) with a Buy and maintains $25 pr...

Core News & Articles

Target enrollment of 100 patients with high-risk, BCG-unresponsive NMIBC with CIS achievedenGene plans to provide an update fro...

Core News & Articles

Regenerative Medicine Advanced Therapy (RMAT) designation provides access to accelerated development toolsDesignation recognize...

Core News & Articles

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

JMP Securities analyst Silvan Tuerkcan reiterates enGene Holdings (NASDAQ:ENGN) with a Market Outperform and maintains $18 p...

Core News & Articles

Morgan Stanley analyst Jeffrey Hung maintains enGene Holdings (NASDAQ:ENGN) with a Overweight and lowers the price target fr...

Core News & Articles

HC Wainwright & Co. analyst Andres Maldonado reiterates enGene Holdings (NASDAQ:ENGN) with a Buy and maintains $25 price...

Core News & Articles

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

Piper Sandler analyst Allison Bratzel initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Overweight rating and annou...

Core News & Articles

UBS analyst Colin Bristow downgrades enGene Holdings (NASDAQ:ENGN) from Buy to Neutral and lowers the price target from $34 ...

Core News & Articles

JMP Securities analyst Silvan Tuerkcan reiterates enGene Holdings (NASDAQ:ENGN) with a Market Outperform and maintains $18 p...

Core News & Articles

HC Wainwright & Co. analyst Andres Maldonado initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Buy rating and a...

Core News & Articles

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1...

Core News & Articles

JMP Securities analyst Silvan Tuerkcan reiterates enGene Holdings (NASDAQ:ENGN) with a Market Outperform and maintains $18 p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION